Terms: = Endocrine gland cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Staging
37 results:
1. Relationship between circulating tumour DNA and skeletal muscle stores at diagnosis of pancreatic ductal adenocarcinoma: a cross-sectional study.
Hanna L; Sellahewa R; Huggins CE; Lundy J; Croagh D
Sci Rep; 2023 Jun; 13(1):9663. PubMed ID: 37316578
[TBL] [Abstract] [Full Text] [Related]
2. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
[TBL] [Abstract] [Full Text] [Related]
3. Thirty-Year-Old Male Patient with Non-Seminoma and Coincidental Rectal cancer.
Nolting J; Dräger DL; Hakenberg OW; Schneidewind L
Urol Int; 2023; 107(4):429-432. PubMed ID: 36652931
[TBL] [Abstract] [Full Text] [Related]
4. Multimodal survival prediction in advanced pancreatic cancer using machine learning.
Keyl J; Kasper S; Wiesweg M; Götze J; Schönrock M; Sinn M; Berger A; Nasca E; Kostbade K; Schumacher B; Markus P; Albers D; Treckmann J; Schmid KW; Schildhaus HU; Siveke JT; Schuler M; Kleesiek J
ESMO Open; 2022 Oct; 7(5):100555. PubMed ID: 35988455
[TBL] [Abstract] [Full Text] [Related]
5. Ferroptosis-based molecular prognostic model for adrenocortical carcinoma based on least absolute shrinkage and selection operator regression.
Lin C; Hu R; Sun F; Liang W
J Clin Lab Anal; 2022 Jun; 36(6):e24465. PubMed ID: 35500219
[TBL] [Abstract] [Full Text] [Related]
6. Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.
Semsar-Kazerooni K; Morand GB; Payne AE; da Silva SD; Forest VI; Hier MP; Pusztaszeri MP; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2022 Mar; 51(1):9. PubMed ID: 35246262
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of circulating cell-free kras mutational status as a molecular monitoring tool in patients with pancreatic cancer.
Schlick K; Markus S; Huemer F; Ratzinger L; Zaborsky N; Clemens H; Neureiter D; Neumayer B; Beate AS; Florian S; Martin V; Grundbichler M; Weiss L; Melchardt T; Greil R; Egle A
Pancreatology; 2021 Dec; 21(8):1466-1471. PubMed ID: 34511398
[TBL] [Abstract] [Full Text] [Related]
8. Molecular Peritoneal staging for Pancreatic Ductal Adenocarcinoma Using Mutant kras Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial.
Yonkus JA; Alva-Ruiz R; Abdelrahman AM; Leiting JL; Schneider AR; Grotz TE; Cleary SP; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Truty MJ
J Am Coll Surg; 2021 Jul; 233(1):73-80.e1. PubMed ID: 34022414
[TBL] [Abstract] [Full Text] [Related]
9. A Multianalyte Panel Consisting of Extracellular Vesicle miRNAs and mRNAs, cfDNA, and CA19-9 Shows Utility for Diagnosis and staging of Pancreatic Ductal Adenocarcinoma.
Yang Z; LaRiviere MJ; Ko J; Till JE; Christensen T; Yee SS; Black TA; Tien K; Lin A; Shen H; Bhagwat N; Herman D; Adallah A; O'Hara MH; Vollmer CM; Katona BW; Stanger BZ; Issadore D; Carpenter EL
Clin Cancer Res; 2020 Jul; 26(13):3248-3258. PubMed ID: 32299821
[TBL] [Abstract] [Full Text] [Related]
10. Lymphatic vessel remodeling and invasion in pancreatic cancer progression.
Shen CN; Goh KS; Huang CR; Chiang TC; Lee CY; Jeng YM; Peng SJ; Chien HJ; Chung MH; Chou YH; Hsieh CC; Kulkarni S; Pasricha PJ; Tien YW; Tang SC
EBioMedicine; 2019 Sep; 47():98-113. PubMed ID: 31495721
[TBL] [Abstract] [Full Text] [Related]
11. Glucose metabolism during tumorigenesis in the genetic mouse model of pancreatic cancer.
Pasquale V; Dugnani E; Liberati D; Marra P; Citro A; Canu T; Policardi M; Valla L; Esposito A; Piemonti L
Acta Diabetol; 2019 Sep; 56(9):1013-1022. PubMed ID: 30989379
[TBL] [Abstract] [Full Text] [Related]
12. Expression of miRNA-143 in Pancreatic cancer and Its Clinical Significance.
Xu B; Liu J; Xiang X; Liu S; Zhong P; Xie F; Mou T; Lai L
Cancer Biother Radiopharm; 2018 Nov; 33(9):373-379. PubMed ID: 30004802
[TBL] [Abstract] [Full Text] [Related]
13. The Evolving Role of Pathology in New Developments, Classification, Terminology, and Diagnosis of Pancreatobiliary Neoplasms.
Reid MD; Lewis MM; Willingham FF; Adsay NV
Arch Pathol Lab Med; 2017 Mar; 141(3):366-380. PubMed ID: 28055239
[TBL] [Abstract] [Full Text] [Related]
14. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.
Ankeny JS; Court CM; Hou S; Li Q; Song M; Wu D; Chen JF; Lee T; Lin M; Sho S; Rochefort MM; Girgis MD; Yao J; Wainberg ZA; Muthusamy VR; Watson RR; Donahue TR; Hines OJ; Reber HA; Graeber TG; Tseng HR; Tomlinson JS
Br J Cancer; 2016 Jun; 114(12):1367-75. PubMed ID: 27300108
[TBL] [Abstract] [Full Text] [Related]
15. Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer.
Bournet B; Gayral M; Torrisani J; Selves J; Cordelier P; Buscail L
World J Gastroenterol; 2014 Aug; 20(31):10758-68. PubMed ID: 25152579
[TBL] [Abstract] [Full Text] [Related]
16. Applications of endoscopic ultrasound in pancreatic cancer.
Luz LP; Al-Haddad MA; Sey MS; DeWitt JM
World J Gastroenterol; 2014 Jun; 20(24):7808-18. PubMed ID: 24976719
[TBL] [Abstract] [Full Text] [Related]
17. Mutational status of kras, NRAS, and BRAF in primary clear cell ovarian carcinoma.
Zannoni GF; Improta G; Chiarello G; Pettinato A; Petrillo M; Scollo P; Scambia G; Fraggetta F
Virchows Arch; 2014 Aug; 465(2):193-8. PubMed ID: 24889043
[TBL] [Abstract] [Full Text] [Related]
18. Trismus and diffuse polymyalgia: an unusual presentation of recurrent metastatic ovarian cancer.
Benjamin R; Zhai J; Morgan R; Prakash N
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24835804
[TBL] [Abstract] [Full Text] [Related]
19. Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome.
Avril S; Hahn E; Specht K; Hauptmann S; Höss C; Kiechle M; Höfler H; Schmalfeldt B
Gynecol Oncol; 2012 Dec; 127(3):516-24. PubMed ID: 23000388
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer.
Ogura T; Yamao K; Hara K; Mizuno N; Hijioka S; Imaoka H; Sawaki A; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
J Gastroenterol; 2013 May; 48(5):640-6. PubMed ID: 22983505
[TBL] [Abstract] [Full Text] [Related]
[Next]
